EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Acute Kidney Injury During Vancomycin Treatment in Adult Patients With Haematologic Malignancies: A Multicentre Retrospective Study

Yuzhu Wang iD, Jie Li, Xingyun Hou iD, Ying Zhang, Chengchun Zuo, Xiaoqiang Ding, Xiaoyu Li, Qianzhou Lv, Hejin Lai, Kunming Pan iD

Basic & Clinical Pharmacology & Toxicology · 2026-09 · 139 (3)

DOI: 10.1111/bcpt.70297 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 23.08.2026. Verfasst von Yuzhu Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhongshan Hospital Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Vancomycin, Acute Kidney Injury, Anti-Bacterial Agents, Hematologic Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shanghai Municipal Health Commission, National Natural Science Foundation of China, Shanghai 'Rising Stars of Medical Talent' Youth Development Program Youth Medical Talents-Clinical Pharmacist Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute kidney injury (AKI) during vancomycin treatment remains a rare occurrence in adult patients with haematological malignancies (HMs). The objective of this multicentre study was to investigate the incidence and risk factors for AKI during vancomycin treatment in patients with HM.

Methods

The present study examined patients who were admitted to hospital and receiving vancomycin therapy between 2009 and 2024 at three tertiary hospitals. The primary outcome was the incidence of AKI during vancomycin treatment.

Results

The study comprised a total of 610 out of 982 patients. The incidence of AKI during vancomycin treatment among patients with HM was 13.0% (79/610). Multiple logistic regression analysis revealed that cardiac insufficiency (OR 3.305, 95% CI = 1.498–7.290, p = 0.003), chronic kidney disease (OR 5.074, 95% CI = 1.636–15.735, p = 0.005), hypoalbuminaemia (OR 2.930, 95% CI = 1.515–5.664, p = 0.001), concomitant spironolactone (OR 3.362, 95% CI = 1.586–7.290, p = 0.002) and chemotherapeutic drugs (OR 6.683, 95% CI = 2.025–22.051, p = 0.002) were independent risk factors for AKI during vancomycin treatment.

Conclusion

The occurrence of AKI in adult patients with HM during vancomycin treatment is a prevalent issue and is associated with a number of clinical and treatment‐related factors. HM patients with cardiac dysfunction, chronic kidney disease, hypoalbuminaemia or concomitant spironolactone, chemotherapeutic agents may have a higher risk of AKI during vancomycin treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAcute Kidney InjuryAnti-Bacterial AgentsHematologic NeoplasmsHumansFemaleMaleRetrospective StudiesMiddle AgedRisk FactorsAgedIncidenceAdult

Stichwörter der Autor:innen

acute kidney injuryadult patientshaematological malignancyrisk factorsvancomycin

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Zhongshan Hospital Fudan University, Shanghai, China.
  • Department of Pharmacy, Tongji Hospital of Tongji University, Shanghai, China.
  • Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
  • Department of Nephrology, Zhongshan Hospital Fudan University, Shanghai, China.
  • CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Shanghai, China.
  • Department of Pharmacy, Zhongshan Hospital, Fudan University (Xiamen Branch), Xiamen, China.

ORCID-Profile: Yuzhu Wang, Xingyun Hou, Kunming Pan

Förderung

  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China
  • Shanghai 'Rising Stars of Medical Talent' Youth Development Program Youth Medical Talents-Clinical Pharmacist Program
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Wang, Y., Li, J., Hou, X., Zhang, Y., Zuo, C., Ding, X., Li, X., Lv, Q., Lai, H., & Pan, K. (2026). Acute Kidney Injury During Vancomycin Treatment in Adult Patients With Haematologic Malignancies: A Multicentre Retrospective Study. Basic & Clinical Pharmacology & Toxicology, 139(3). https://doi.org/10.1111/bcpt.70297

Vancouver

Wang Y, Li J, Hou X, Zhang Y, Zuo C, Ding X, et al. Acute Kidney Injury During Vancomycin Treatment in Adult Patients With Haematologic Malignancies: A Multicentre Retrospective Study. Basic & Clinical Pharmacology & Toxicology. 2026;139(3). doi:10.1111/bcpt.70297

BibTeX
@article{Wang2026,
  author = {Wang, Yuzhu and Li, Jie and Hou, Xingyun and Zhang, Ying and Zuo, Chengchun and Ding, Xiaoqiang and Li, Xiaoyu and Lv, Qianzhou and Lai, Hejin and Pan, Kunming},
  title = {Acute Kidney Injury During Vancomycin Treatment in Adult Patients With Haematologic Malignancies: A Multicentre Retrospective Study},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  volume = {139},
  number = {3},
  doi = {10.1111/bcpt.70297}
}
Kostenlos starten →